The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease.

Clin Kidney J · 2015 · PMC4440476 · PMID 26034594

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The CAPiTA trial demonstrates a highly significant 45.6% [95% CI (21.8–62.5)] reduction in first episode of vaccine-type CAP, a 45.0% [95% CI (14.7–65.3)] reduction in first episode of non-bacteraemic/noninvasive vaccine-type CAP and a 75% [95% CI (41.4–90.8)] reduction in first episode of vaccine-type IPD, with, however, no effect on overall mortality [ 12 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.